AI assistant
SYNOPSYS INC — Director's Dealing 2025
Jan 16, 2025
29855_dirs_2025-01-16_d3f390e4-39e1-43c3-a5e2-cf49424eab0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SYNOPSYS INC (SNPS)
CIK: 0000883241
Period of Report: 2025-01-15
Reporting Person: MAHONEY RICHARD S. (Chief Revenue Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-15 | Common Stock | M | 10322 | $319.2 | Acquired | 18125 | Direct |
| 2025-01-15 | Common Stock | S | 10322 | $505.9868 | Disposed | 7803 | Direct |
| 2025-01-15 | Common Stock | M | 4173 | $354.45 | Acquired | 11976 | Direct |
| 2025-01-15 | Common Stock | S | 4173 | $505.9672 | Disposed | 7803 | Direct |
| 2025-01-15 | Common Stock | S | 6343 | $506.071 | Disposed | 1460 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-15 | Non-Qualified Stock Option (right to buy) | $319.2 | M | 10322 | Disposed | 2029-05-31 | Common Stock (10322) | Direct |
| 2025-01-15 | Non-Qualified Stock Option (right to buy) | $354.45 | M | 4173 | Disposed | 2030-02-17 | Common Stock (4173) | Direct |
Footnotes
F1: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $501.74 to $508.60. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $501.74 to $509.00. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2024.
F4: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.